Janssen has announced a significant investment to expand its R&D presence and capabilities in the San Francisco Bay Area. This investment will support the leasing and construction of a state-of-the-art R&D facility in the global innovation center of South San Francisco, CA. Janssen executed the lease at The Shore at Sierra Point in Brisbane, CA. Janssen personnel at this new facility will focus on infectious and retinal diseases, data science and emerging modalities within discovery, product development and supply. The expanded facility is projected to more than double Janssen’s presence in South San Francisco and is anticipated to be fully operational in 2022, upon completion of construction. Learn More